COMBINED ANTICANCER DRUG SENSITIVITY-DETERMINING MARKER

Provided are an anticancer sensitivity-determining marker by which responsiveness to treatment of individual patients can be discriminated and a novel cancer treatment means using the same. A marker for determining the sensitivity to an anticancer drug including oxaliplatin or a salt thereof and flu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TAKAHASHI, HIROYUKI, TSUZAKI, JUNYA, NISHIMUTA, AKITO, TANIGAWARA, YUSUKE
Format: Patent
Sprache:eng ; fre ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!